NEJM at ESMO — Ponsegromab in Cancer Cachexia
In this audio interview, Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research being presented at the 2024 European Society of...
No One in Charge
A chance encounter with a retired military officer who recently lost his wife to cancer raises questions for a retired pediatrician about medical hierarchy,...
Pembrolizumab in HER2-Positive Gastric Cancer
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
NEJM at ESMO — Pembrolizumab in HER2+ Gastric Cancer
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
Preoperative Chemoradiotherapy for Resectable Gastric Cancer
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
